The bioorthogonal keto group has attracted interest for the site-specific chemical conjugation of recombinant proteins under mild conditions, e.g. with aminooxy-functionalised fluorescent probes, radiometal chelates, toxins or polymers. However, the cotranslational incorporation of the corresponding non-canonical amino acid p-acetyl-L-phenylalanine (Apa) into proteins expressed in Escherichia coli by means of amber suppression using a previously described system with a mutated tRNA and an engineered tyrosyl-tRNA synthetase from Methanococcus jannaschii shows limited efficiency and considerable promiscuity towards endogenous amino acids. Employing a one-plasmid system that encodes all three components required for selection, i.e. the modified aminoacyl-tRNA synthetase (aaRS), the cognate amber suppressor tRNA and the enhanced green fluorescent protein equipped with an amber stop codon and serving as reporter, we have generated an Apa-specific aaRS&tRNA pair with considerably improved efficiency (17-fold increased expression) and also fidelity (6-fold). To this end, both the aaRS and the tRNA were subjected to doped random mutagenesis and selection in altogether four evolutionary cycles using fluorescence-activated bacterial cell sorting as well as automated screening of microcultures. The resulting aaRS&tRNA pair was applied to the functionalisation of an Anticalin with specificity towards oncofetal fibronectin by introducing a keto group at a permissible site for subsequent conjugation with a fluorescent dye, thus allowing visualisation of this tumour target under the microscope.
Introduction
The biosynthesis of proteins with non-proteinogenic amino acids opens the way to novel biomolecular reagents for biophysical, structural or biochemical research as well as biotechnological and biopharmaceutical applications (Wals and Ovaa, 2014) . A versatile method for the site-specific incorporation of non-canonical amino acids (NCAAs) must exploit a nucleic acid codon that is not actively used by the genetic code of the host cell. Thus, the amber stop codon (UAG), which is also subject to natural nonsense suppression mechanisms, has been recruited as an additional coding triplet for novel amino acids to provide new side chain chemistries. Initially developed for in vitro translation systems employing synthetic aminoacyl-tRNAs, this general approach has been adapted to the heterologous overexpression of proteins in live cells, further necessitating an artificial aminoacyl-tRNA synthetase (aaRS) with the desired substrate specificity . Importantly, such a synthetase must not aminoacylate any endogenous cellular tRNA, whereas the cognate suppressor tRNA, which is co-overexpressed in vivo, must not be aminoacylated with a natural amino acid by any endogenous synthetase.
After various endeavours to develop such an 'orthogonal pair' of tRNA and aaRS for in vivo translation in Escherichia coli, an efficient combination was found in the tyrosyl-tRNA synthetase (TyrRS) from the archaebacterium Methanococcus jannaschii (Mj) and its cognate tRNA Tyr that was mutated to specifically recognise and suppress the amber stop codon . To engineer TyrRS for novel amino acid specificities, a set of residues in its active site was mutagenised, initially allowing the site-specific incorporation of O-methyl-L-tyrosine (MeTyr) into dihydrofolate reductase ). Since then, over 70 NCAAs have been added to the genetic code of E.coli via this approach (Liu and Schultz, 2010) . Up to now, in vitro evolution schemes for aaRS enzymes with novel substrate specificities made use of antibiotic selection in conjunction with resistance genes carrying an amber stop codon and/or survival in the presence of amber-inactivated toxic genes (e.g. encoding barnase) to eliminate mutated synthetases that also accept endogenous amino acids . We have recently developed an alternative strategy for the rapid selection of mutant aaRS with specificities for NCAAs based on fluorescence-activated cell sorting (FACS) of transformed E.coli using as reporter the enhanced green fluorescent protein (eGFP) whose gene was equipped with an amber stop codon at a permissive site upstream of the fluorophore (Kuhn et al., 2010) . To this end, a one-plasmid expression system was constructed encoding a modified Mj TyrRS, the cognate suppressor tRNA and eGFP UAG39 in an individually regulatable fashion. Using this system, a previously described aaRS with specificity for MeTyr ) was engineered for 10-fold improved incorporation of the foreign amino acid via selection from a mutant TyrRS library towards MeTyr-dependent eGFP fluorescence. As it turned out, applying alternating cycles of positive and negative FACS selection in the presence or absence, respectively, of MeTyr was crucial to achieve high amino acid specificity. While MeTyr is primarily of interest for its spectroscopic properties as well as its capacity of hydrophobic packing interactions, other amino acid side chains with distinct chemical reactivities appear attractive in order to implement novel functionalities into engineered proteins. In this regard, the keto group constitutes one of the most versatile functional groups in organic chemistry and provides biochemical 'orthogonality' because it (i) is generally absent in genetically encoded polypeptides and (ii) does not readily react with natural amino acid side chains under physiological conditions (Sletten and Bertozzi, 2009 ). On the other hand, if employing hydrazine or hydroxylamine (aminooxy) derivatives of relevant compounds, the keto group allows regiospecific protein conjugation both in vitro and in vivo , yielding hydrazone or oxime adducts, respectively. Notably, such coupling can be carried out under just slightly acidic conditions ( pH 4.5-7.0), which is compatible with most native proteins (Mahal et al., 1997) . Consequently, the biosynthetic (cotranslational) functionalisation of proteins and peptides with keto groups is an ideal method to incorporate further post-translational modifications by simple chemical conjugation, thus expanding the toolbox of protein engineering.
In this context, p-acetyl-L-phenylalanine (Apa) offers an easily accessible NCAA containing a keto group for incorporation into functional proteins, such as for example Anticalins, a novel class of small binding proteins based on the lipocalin scaffold (Richter et al., 2014) . Anticalins with high affinities and specificities have been selected against several disease-relevant targets, including oncofetal fibronectin with its extra-domain B (ED-B), which serves as an established marker of tumour angiogenesis (Gebauer et al., 2013) . The sitespecific functionalisation of such Anticalins with fluorophores, radiometal chelates or toxins offers prospects for cancer diagnostics and therapy.
Schultz and co-workers have evolved a variant Mj TyrRS with specificity towards the Apa substrate using colony screening methods in combination with antibiotic selection for incorporation of this NCAA into proteins synthesised in E.coli . To improve the catalytic activity as well as fidelity of the published aaRS&tRNA pair towards Apa, we have applied our one-plasmid system in evolutionary cycles involving random mutagenesis of both the aaRS and the suppressor tRNA together with cell sorting using an Apa-dependent fluorescent reporter protein (Kuhn et al., 2010) . With the resulting optimised aaRS&tRNA pair, we have prepared an αED-B Anticalin carrying a reactive keto group and utilised it for site-specific coupling with a fluorescent dye.
Results

A system that enables efficient co-translational incorporation of Apa
For the selection of a new aaRS&tRNA pair specific for Apa, we used a previously established one-plasmid system (Kuhn et al., 2010) that encodes the three components required for selection, all individually regulated by promoters: (i) the gene for the mutated aaRS, (ii) the gene for the cognate amber suppressor tRNA and (iii) the coding region for eGFP UAG39 . In this context, eGFP serves as a convenient fluorescent reporter which can be replaced by other recombinant proteins of interest once an aaRS&tRNA pair with desired properties has been optimised. Read-through of the amber stop codon within the eGFP reading frame at position 39, upstream of its fluorophore, via suppression by the charged foreign tRNA leads to a functional gene product and an easily detectable FACS signal. On the other hand, bacterial fluorescence in the absence of an added NCAA offers a sensitive measure for the non-specific charging of the suppressor tRNA with endogenous amino acids via a promiscuous aaRS variant. This system, which enables both positive and negative selection cycles in a controlled manner, was applied to the engineering of an ApaRS&tRNA pair with advanced functionality.
The four side chain exchanges ( Table I) described for a variant of Mj TyrRS that accepts Apa as substrate were introduced into the Mj TyrRS wild-type gene cloned on the one-plasmid system (Kuhn et al., 2010) via site-directed mutagenesis to yield the so-called variant ApaRS#0. Also, the originally engineered cognate suppressor tRNA Tyr CUA ) was replaced by the . The variants ApaRS#B4, ApaRS#A10 and ApaRS#H8 were successively improved in the present study with regard to efficiency of Apa incorporation as well as amino acid substrate fidelity by applying several cycles of directed evolution (see Fig. 1 ). Residues differing from the Mj TyrRS wild-type sequence (lower case) are shown in upper-case letters, those differing from ApaRS#0 are highlighted in bold.
optimised version tRNA opt CUA (Guo et al., 2009; , here dubbed tRNA#0. The performance of this aaRS&tRNA pair in terms of fidelity and Apa incorporation efficiency was tested using the eGFP UAG39 fluorescence signal as readout. FACS analysis revealed that bacterial cell fluorescence levels in the absence of the NCAA approached 80% of the level that was observed after adding L-Apa (1 mM) to the LB growth medium, thus indicating a high level of background amino acid incorporation and, hence, considerable room for functional improvement. Therefore, the coding region for ApaRS#0 was subjected to a directed evolution approach, which involved generation of gene libraries by error-prone mutagenesis as well as positive and negative bacterial cell sorting on a FACSAria instrument, followed by single-clone analysis of eGFP fluorescence in 96-well plate microcultures using a robotic platform. The best ApaRS variant resulting from one selection cycle served as template for generation of the next random library (Fig. 1) . Screening of the first two libraries resulted in the consecutively improved ApaRS variants ApaRS#B4 and ApaRS#A10, respectively. In parallel, to improve the combined ApaRS&tRNA pair, we also generated a random library of the engineered tRNA#0 (cf. Fig. 1 ). Again, error-prone polymerase chain reaction (PCR) was used to mutagenise this short gene (77 nucleotides), which was followed by FACS selection and single-clone analysis in the context of ApaRS#A10. Based on the resulting tRNA#B5 and ApaRS#A10, a positional saturation mutagenesis led to the final optimised variant of the synthetase, ApaRS#H8 (cf. Table I ).
Selection of an improved Apa-specific aaRS
A first attempt to improve the aaRS activity towards Apa was made by non-directed mutagenesis at moderate frequency (2-4 nucleotide substitutions across the central gene cassette encoding amino acid residues 20-217; cf. UniProt ID Q57834). Using the ApaRS#0 gene as template, a random library with 5 × 10 8 transformants was prepared by means of error-prone PCR with a pair of primers that flanked the central coding region and allowed unidirectional cloning via a pair of mutually non-compatible type IIS restriction sites (EarI). This mutant library was submitted to in total four negative and three positive cycles of bacterial cell sorting on a FACSAria cytofluorimeter. Initial analysis of this first ApaRS random library revealed a significant eGFP fluorescence level already in the absence of Apa, indicating substantial non-specific incorporation of endogenous amino acids by ApaRS#0 and the majority of its mutants (Fig. 2) . To enrich ApaRS variants with higher fidelity, two successive 'negative selection' steps were performed first, i.e. the bacterial population was grown and induced in the absence of Apa and sorted for low eGFP fluorescence. After that, no significant fluorescence level was detectable ( Fig. 2A,  cycle 3 ). Subsequently, in the course of five alternating cycles of positive (i.e. with addition of 1 mM Apa) and negative selection, a fluorescence response indicating specific incorporation of Apa clearly developed ( Fig. 2A) . After the final positive selection cycle, the resulting bacterial population was subjected to single-clone analysis in 96-well microcultures using a robotic platform.
In this assay, 93 randomly chosen colonies were propagated and analysed individually for eGFP fluorescence after induction of gene expression both in the presence and in the absence of Apa using a microplate reader. Out of this screen, five clones which showed the best ratio between corresponding eGFP fluorescence intensities were sequenced and chosen for individual FACS analysis (data not shown). The best clone in terms of efficiency and fidelity, ApaRS#B4, did not yield a significant increase in mean eGFP fluorescence (i.e. better Apa incorporation) versus the starting variant ApaRS#0 but revealed a 2-fold enhanced specificity for Apa (i.e. lower unspecific amber suppression; see below). Sequence analysis of ApaRS#B4 indicated two additional amino acid substitutions compared with ApaRS#0, His160Gln and Glu78Val, while all four original mutations of ApaRS#0 were retained (Table I ). Looking at the published crystal structure of ApaRS#0 Fig. 1 Overview of the FACS selection process for an optimised orthogonal aaRS&tRNA pair. Both activity and fidelity of a published aaRS&tRNA pair for incorporation of Apa into eGFP UAG39 , serving here as a fluorescent reporter protein, were improved in the course of several evolutionary cycles by applying random mutagenesis followed by cytofluorimetric cell sorting. Engineering of both the ApaRS and the cognate suppressor tRNA resulted in 17-fold increased recombinant protein yields and 6-fold better discrimination of Apa against the natural amino acid Tyr.
at Technical University Munich on November 15, 2016 http://peds.oxfordjournals.org/ Downloaded from (Turner et al., 2005) , the new substitution His160Gln is situated in proximity to the active centre of the enzyme and could act as functionally relevant second-shell mutation (Fig. 3) whereas residue 78 is farther apart and may be involved in the interaction with the tRNA.
To further analyse ApaRS#B4, eGFP Apa39 was expressed in a 50 ml shake-flask culture of E.coli BL21 transformed with the one-plasmid system. The biosynthetic protein was visible on SDS-PAGE as a faint band in the total cell extract (data not shown). Furthermore, compared with ApaRS#0, the culture harbouring the gene for ApaRS#B4 reached 4-fold higher final optical density (OD 550 ) in LB medium after 12 h induction of gene expression at 30°C, thus indicating a reduced toxic effect of this ApaRS variant on the host cell. ApaRS#B4 was used as starting point for another cycle of random mutagenesis via error-prone PCR, yielding an aaRS library (6 × 10 8 transformants) that was subjected to negative and positive FACS selection cycles as before. After the first negative selection, the library showed already a very low level of eGFP fluorescence, which obviated the need for a repeated negative selection like in the previous experiment. The possibility to react in such a dynamic manner on the behaviour of a complex gene library illustrates the benefit of FACS technology. After in total six alternating FACS cycles, bacterial cells were recovered on agar medium, followed by single-clone analysis in the 96-well microculture format.
This time, 181 colonies were analysed as above and of those four clones showed a pronounced fluorescence ratio (Fig. 2B) , thus indicating high specific expression of the eGFP reporter in the presence of Apa but low expression in its absence. Sequence analysis of the mutated aaRS gene cassettes revealed that the clone with the highest fluorescence ratio (well A10), dubbed ApaRS#A10, carried the same aaRS mutant as those in wells F7, H5 and G4, i.e. the next best hits. ApaRS#A10 showed one additional amino acid exchange, Lys101Glu, while all previous mutations from ApaRS#B4 were conserved (Table I) . Judged from the crystal structure of ApaRS#0, the substitution Lys101Glu is somewhat distant to the active site (14.7 Å between the Cα position and the carbonyl carbon of the bound Apa) but could exert a longrange electrostatic effect (due to the netto change of two charge units), possibly even leading to a salt bridge with the previously mutated residue Arg162 (cf. Fig. 3 and Table I ). Compared with ApaRS#B4, the variant ApaRS#A10 showed a higher level of amber Fig. 2 Overview of the FACS selection and microtiter plate screen for Apa-specific aaRS with enhanced activity. (A) Exemplary FACS data from the first selection, starting with an error-prone library (broken lines) based on ApaRS#0, as well as analysis of relevant clones (solid lines) throughout the entire course of in vitro evolution (cf. Fig. 1 ). eGFP UAG39 fluorescence was quantified after expression either in the presence of Apa or in its absence (supplementing Tyr instead). To aid the comparison between eGFP-positive and -negative signals, a vertical line indicates a typical fluorescence threshold (note that the window used for library sorting was usually more stringent). During the 1st selection, two successive negative sorts were initally performed to eliminate unspecific background amber suppression (leading to cycle no. 3) and followed by alternating positive/negative sorting cycles, eventually resulting in the variant ApaRS#B4. The finally optimised variant ApaRS#H8 is shown for comparison. (B) Single-clone analysis of eGFP fluorescence in connection with the second selection performed with E.coli cultures in 96-well assay plates. Fluorescence signals (excitation at 485 ± 10 nm, emission at 528 ± 10 nm) were normalised to the OD 550 of the culture in each well and background fluorescence (measured for the mock pSB4 vector encoding no eGFP) was subtracted. Finally, specific fluorescence was reported as ratio eGFP +Apa /eGFP +Tyr . For comparison, wells A2-A5 (light grey) represent ApaRS#B4, which had served as template for this error-prone mutagenesis. The best hit in this screen was found in well A10 (dubbed ApaRS#A10), harbouring the same aaRS mutant as in wells F7, H5 and G4 (dark grey).
suppression in the presence of Apa, in conjunction with a further decreased background activity in the absence of the foreign amino acid (see below).
Following optimisation of the cognate suppressor tRNA, which will be described in the next section, a focused random library was designed on the basis of ApaRS#A10 with the aim to eliminate two Cys residues occurring in this aaRS variant as well as its predecessors. Cys159 in the active site was selected during the initial generation of ApaRS#0 and appeared chemically modified with 2-mercaptoethanol in the crystal structure (Turner et al., 2005) . The solvent-accessible Cys231 was found already in the wild-type Mj TyrRS (Zhang et al., 2005) and seems to play a role in anticodon recognition of the tRNA (Kobayashi et al., 2003) . Even though normally protected against oxidation in the reducing cytoplasmic milieu, such exposed thiol side chains constitute potentially reactive sites that might be of disadvantage in future applications. Thus, both Cys positions were randomised in a targeted manner using a pair of degenerate PCR primers. A focused random library with 5 × 10 7 transformants was subjected to selection, as described above. After six cycles of negative/positive cell sorting, 180 clones were analysed. As result, a new mutant was identified, dubbed ApaRS#H8, which (in the context of tRNA#0) showed a 1.6-fold higher eGFP fluorescence ratio compared with ApaRS#A10 and carried the two mutations Cys159Ala and Cys231Ile (cf. Table I ). Hence, none of the two thiol side chains seems to be functionally crucial for the engineered Apa-specific aaRS.
Selection of an improved orthogonal amber suppressor tRNA
To complement our efforts to functionally improve the Apa-specific aaRS via combinatorial protein engineering, we also sought to optimise the cognate suppressor tRNA in this context. Notably, since its first description ) the engineered Mj tRNA Tyr , which carries a mutated anticodon in order to recognise the amber stop codon as well as four additional mutations, has been used without further changes in most of the other studies aiming at the engineering of mutant aaRS with novel amino acid specificities, including the one that led to ApaRS#0 . In this experiment, we prepared a mutated tRNA library on the basis of a recently optimised suppressor tRNA opt CUA that has another six nucleotides exchanged within the T-arm (50-52 and 64-66) , here dubbed tRNA#0, by subjecting the entire region comprising nucleotides 1-77 to error-prone PCR mutagenesis (as above for the aaRS), yielding ∼10 7 transformants.
Using our one-plasmid system with the cloned ApaRS#A10 enzyme as background, this suppressor tRNA library was employed for two negative and four positive FACS selection cycles. As before, cells with the highest levels of eGFP fluorescence in the presence of Apa were sorted during positive selection, whereas cells with a low fluorescence signal in the absence of Apa were sorted during negative selection. This strategy served to favour tRNA variants that are viable substrates for the engineered ApaRS but unable to suppress the amber stop codon in the context of endogenous aaRS. After in total six FACS cycles, 260 clones were analysed using robotic screening of microcultures as described above.
Interestingly, the five best clones in terms of eGFP fluorescence ratio resulting from this screen all showed the same single nucleotide mutation U46G in the 'variable' tRNA region (Fig. 3B ). This type of mutation was not found in previously published screening experiments, including a study aiming at optimised binding to EF-Tu (Guo et al., 2009; . Analysis of the evolving eGFP Apa39 fluorescence intensity in the presence of the foreign amino acid over time revealed that the new tRNA variant was able to generate the fluorescence signal significantly faster during the first 5 h after induction compared with tRNA#0 (see below). Hence, we were able to select a functionally enhanced suppressor tRNA, dubbed tRNA#B5, which still shows high orthogonality with endogenous aaRS but boosts the kinetics of protein biosynthesis upon cotranslational incorporation of Apa. Table I ), whereas the additional mutations Glu78Val, Lys101Glu, Ile(Cys)159Ala, His160Gln and Cys231Ile in the optimised variant ApaRS#H8, which were modelled with plausible side chain conformations using a backbone-dependent rotamer library (Shapovalov and Dunbrack, 2011) , are highlighted in pink. (B) Nucleotide positions differing in the original engineered suppressor tRNA#0 from the wild-type Mj tRNA Tyr sequence ) are highlighted in bold letters.
The encircled single mutation in the 'variable' region (U46G) of tRNA#B5 boosts expression kinetics of an amber-carrying recombinant protein in the presence of Apa.
Functional characterisation of the optimised Apa-specific aaRS&tRNA pair
Clones harbouring the selected ApaRS variants as well as the original or improved suppressor tRNAs were individually re-analysed via FACS (Fig. 4) by measuring the fluorescence intensity with addition of either 1 mM Apa or 1 mM Tyr to the culture medium. Compared with ApaRS#0, all newly selected ApaRS variants showed a significant decrease in amber suppression of the GFP UAG39 reporter gene in the absence of the NCAA, thus clearly indicating a lower degree of promiscuity. Hence, the two novel amino acid substitutions Glu78Val and His160Gln in the synthetase variant ApaRS#B4 already had led to improved specificity for the foreign amino acid, in line with the strong 'negative' selection pressure applied during the first evolutionary cycle. Notably, according to the crystal structure of ApaRS#0, position 160 is located at the end of an α-helix (146-164) that forms the bottom of the amino acid substrate pocket (Turner et al., 2005) . The second mutation that has occurred in ApaRS#B4, Glu78Val, is located on the surface of the synthetase, pointing towards the bound suppressor tRNA (Kobayashi et al., 2003) ; hence, it seems not to play a direct role in the recognition of the amino acid substrate while its functional significance in the course of the dynamics of the aaRS catalytic cycle is difficult to assess.
The variant ApaRS#A10 derived from the second evolutionary cycle not only showed further decreased background amber suppression but also a significantly increased activity towards Apa. This is the result of one additional side chain replacement, Lys101Glu, which is located in the second shell around the aaRS active site, at a position that did not become evident in previous studies . Finally, the focused mutagenesis in the third selection cycle led to the substitutions Cys159Ala and Cys231Ile in the variant ApaRS#H8. Since the original Ile159Cys mutation in ApaRS#0 was described to enlarge the binding pocket for the more extended side chain of Apa compared with Tyr , Ala with its smaller side chain at this position should leave even more space for the bulky substrate. While this aaRS variant showed a significant increase in amber suppression in the presence of Apa in rich culture medium (12-fold relative to ApaRS#0) it also revealed slightly higher unspecific amber suppression compared with ApaRS#A10, i.e. the variant with the lowest background so far.
Remarkably, this small detrimental effect in the context of the original suppressor tRNA#0 was overcompensated when tested in combination with the improved tRNA#B5. In this case, the background suppression was reduced to the same low level as for ApaRS#A10 (Fig. 4A) , whereas specific eGFP UAG39 translation was 1.6-fold increased for ApaRS#H8 if compared with ApaRS#A10&tRNA#B5. Another effect of the enhanced tRNA variant became evident in a significant boost of eGFP Apa39 expression kinetics when applying tRNA#B5 in the context of both ApaRS#A10 and ApaRS#H8. Five hours after the induction of eGFP Apa39 gene expression, we observed a 4-fold higher fluorescence intensity in the case of ApaRS#A10&tRNA#B5 and, after 6 h, even an 8-fold higher intensity for ApaRS#H8&tRNA#B5 compared with the original ApaRS#0&tRNA#0 pair (Fig. 4B) .
To investigate the efficiency of Apa incorporation into proteins by using the newly engineered ApaRS#H8&tRNA#B5 pair, we compared its in vivo amber suppression activity with the one of wild-type Mj TyrRS synthetase in the context of tRNA#0 using preparative expression in a rich culture medium. When eGFP UAG39 was translated in the context of ApaRS#H8&tRNA#B5 in LB medium supplemented with 1 mM Apa, eGFP Apa39 was produced at a yield of 3.1 mg/l medium ( Fig. 4C ) as determined after purification by means of the C-terminal Strep-tag II, followed by anion-exchange chromatography (AEX). eGFP Tyr39 produced under the same expression conditions using a plasmid encoding Mj TyrRS&tRNA#0 and LB medium supplemented with 1 mM Tyr yielded 4.6 mg/l medium. Thus, our evolved aaRS&tRNA pair showed 67% incorporation activity towards the foreign amino acid when compared with the underlying wild-type Tyr suppressor system (Fig. 4D) . The identity of the amino acid inserted in response to the amber stop codon was confirmed by electrospray ionization mass spectrometry (ESI-MS; Fig. 4E and F) . Remarkably, only one mass signal for each version of the biosynthetic eGFP protein, i.e. carrying at position 39 either Apa or Tyr-the original substrate of wt Mj TyrRS-was detectable. No distinct peaks corresponding to eGFP UAG39 with any other amino acid at the stop codon position were observed in the spectra, thus confirming the strong discrimination against endogenous amino acids by the improved ApaRS&tRNA pair.
Application of the evolved ApaRS&tRNA pair to the biosynthesis of a keto-derivatised Anticalin in E.coli
To prove the practical utility of the engineered ApaRS#H8&tRNA#B5 combination, we applied our system to the preparation of the Anticalin N7A, which is specific for the neovasculature target ED-B (Gebauer et al., 2013) , functionalised with a bioorthogonal keto group. For the site-specific introduction of Apa, Glu at position 20 on the β-barrel surface of this engineered lipocalin scaffold was chosen. According to its crystal structure, this position is far away from the binding site and solvent accessible, which should facilitate subsequent chemical coupling with a dye or chelator group, for example ( Fig. 5) . The use of the Alexa Fluor-coupled Anticalin for detection of the ED-B tumour antigen on fixed cells via immunofluorescence microscopy. ED-B-positive CaCo2 cells were grown as monolayer on microchamber glass slides, fixed with methanol, and nuclei were counterstained with DAPI. Cells were either incubated with a 1 μM solution of the labelled Anticalin alone (right) or in the presence of a 100-fold excess of the unmodified protein (left). After washing, bound N7A Apa20 -Alexa488 was directly imaged with an Axiovert 40 CFL microscope using appropriate band-pass filters.
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Using our one-plasmid system, the structural gene for eGFP UAG39 was replaced by the coding region for N7A
UAG20
, including the bacterial OmpA signal sequence to direct periplasmic secretion, thus ensuring formation of the single structural disulphide bond in this Anticalin. Recombinant gene expression was performed in a 1 l shakeflask culture of E.coli BL21 in glucose minimal medium supplemented with 1 mM Apa at 22°C, followed by purification of N7A Apa20 to homogeneity from the periplasmic cell extract by means of its C-terminal Strep-tag II and cation-exchange chromatography (CEX). The biosynthetic protein was visible as a prominent band in the periplasmic cell extract (Fig. 5A) , eventually yielding ∼1 mg of purified protein per 1 l of bacterial culture. ESI-MS revealed the predicted mass for the keto-functionalised protein of 22 025.0 Da within 1 Da accuracy (Fig. 5B) . Notably, even if N7A Apa20 was expressed in rich LB medium, no mass signal for the unmodified N7A protein (i.e. carrying at position 20 either the original amino acid Glu or Tyr, the natural substrate of wt Mj TyrRS) was detectable, thus verifying the strong discrimination against endogenous amino acids by the evolved ApaRS&tRNA pair (Fig. 5B, upper inset) . Next, we investigated whether the Apa keto group introduced into the Anticalin can fulfil its role as a reactive group for site-specific chemical protein modification in vitro. To this end, the purified N7A Apa20 protein was incubated with a 50-fold molar excess of Alexa Fluor 488 hydroxylamine in MES/NaOH pH 5.5 at 25°C for 18 h. After that, the protein was separated from the reagent by CEX on a 1 ml Resource S column and analysed via SDS-PAGE. The polyacrylamide gel was first scanned with a fluoroimaging system and then stained with Coomassie brilliant blue (Fig. 5C ), together revealing a homogenous fluorescent single protein band with the expected size for N7A Apa20 -Alexa488. The labelled protein was also analysed by ESI-MS (cf. Fig. 5B , lower inset), proving that the fluorescent aminooxy compound had reacted with N7A Apa20 as expected in a molar ratio 1:1. A control experiment performed with the unmodified N7A protein (expressed as previously described; Gebauer et al., 2013) , incubated with the fluorescent hydroxylamine reagent under analogous conditions, did not reveal any coupling, hence confirming the selectivity of the chemical labelling reaction. Finally, the utility of the fluorescently labelled Anticalin for detection of its biomedical target ED-B was investigated using immunofluorescence microscopy. The human cancer colon cell line CaCo2 expresses the oncofetal splice form of fibronectin and thus provides a convenient model for native ED-B expression on the cell surface (Gebauer et al., 2013) . The purified N7A Apa20 -Alexa488 conjugate was incubated with a cellular monolayer of methanol-fixed CaCo2 cells cultured on a microscope slide. As result, the functionalised Anticalin led to specific and intense fluorescent staining of the cell surface and extracellular matrix (Fig. 5D ).
Discussion
The keto group offers a unique chemical reactivity not present in the common 20 amino acid side chains due to its ability to selectively undergo addition/condensation reactions with certain nitrogen nucleophiles, in particular hydroxylamines and hydrazines, already under more or less physiological conditions. Remarkably, the keto group does neither readily react with other amino acid side chainsor abundant cellular metabolites-nor do its most suitable reaction partners. This concept has become known as bioorthogonal chemistry (Sletten and Bertozzi, 2009 ) and provides a convenient alternative to conjugation with Lys and Cys side chains, still the most widely applied natural amino acids for chemical modification of proteins.
Apa has been proposed as a biosynthetic building block in order to equip proteins with the keto functionality in combination with the cotranslational incorporation of NCAAs via specific amber suppression using an aaRS with engineered substrate specificity . Since then, Apa (also known as pAF) has been employed for the site-directed modification of several proteins with biopharmaceutical relevance, e.g. to achieve PEGylation of human growth hormone (Deiters et al., 2004) or to prepare antibody-drug conjugates (Axup et al., 2012; Tian et al., 2014) . Whereas the original Apa-specific aaRS was engineered on the basis of Mj TyrRS for expression in E.coli , the latter Apa-modified proteins were produced in eukaryotic cell culture-while it remains elusive whether the same aaRS was actually used.
Unfortunately, the published Apa-specific synthetase (ApaRS#0) showed dissatisfactory activity and high background amber suppression in our laboratory when applied to the biosynthesis of modified proteins in E.coli. Notably, the poor discrimination of natural amino acids usually leads to toxic effects on the host cell, which is likely caused by general amber suppression of endogenous gene products whose translation is terminated with this stop codon even before the biosynthesis of the recombinant protein in the presence of the foreign amino acid is induced. Since E.coli provides advantages as expression host over eukaryotic cell culture not only for basic research but also for biopharmaceutical production, we set out to improve ApaRS#0 with regard to Apa substrate specificity and biosynthetic efficacy in this bacterial organism via directed evolution with our previously described one-plasmid system (Kuhn et al., 2010) . As result, we were able to increase the fidelity of the aaRS&tRNA pair and push the preparative protein yield, as exemplified for Apa-derivatised eGFP as well as an Anticalin. In our hands, the greatly reduced toxic effect of the optimised aaRS&tRNA pair led to faster E.coli growth and higher cell densities.
In the original endeavour to change the amino acid specificity of the Mj TyrRS towards Apa, a targeted library of synthetase mutants had been generated by randomising those five residues which are within 6.5 Åof the para aryl position of the bound Tyr substrate, that is the molecular position where the small hydroxyl substituent was to be exchanged against the acetyl group: Tyr32, Asp158, Ile159, Leu162 and Ala167 . In the course of our subsequent in vitro evolution effort, only one of these positions was changed (Cys159Ala) while four additional side chain substitutions were introduced into the engineered synthetase (including the position of Cys231; cf. Table I ). These findings clearly indicate that not only those residues located in the immediate proximity of the amino acid substrate play an important role for synthetase activity and fidelity; rather, mutations in the second shell around the active site can be functionally relevant, too.
The substitution His160Gln occurs at the end of an α-helix (146-164) that forms part of the substrate pocket of ApaRS#0, which could lead to a slight rearrangement of this secondary structural element and, thus, preferred binding of Apa over canonical amino acids. The substitution Glu78Val is situated in the hinge region of two α-helices (67-74 and 78-96), of which one (67-74) covers the active centre laterally and could also influence substrate binding (Fig. 3A) .
Furthermore, mutations may also play a role for the interaction with the tRNA cosubstrate (Glu78Val and Cys231Ile). In fact, the efficiency of an orthogonal aaRS in charging the cognate suppressor tRNA with an NCAA depends on its affinity towards both the amino acid and the tRNA. To decode the amber stop codon (UAG), which is generally used to specify the NCAA position in a recombinant structural gene, the anticodon of the orthogonal tRNA has to be changed to CUA. This alteration often decreases its affinity towards the synthetase as the anticodon is a major recognition element of most aaRS enzymes, including the Mj TyrRS (Ibba and Söll, 2000) . Consequently, compensatory mutations in the aaRS are to be expected.
The C-terminal domain of the Mj TyrRS spanning from residue 210 to 306 recognises the anticodon of the tRNA. This interaction and, thus, its aminoacylation, is mediated primarily through the first base of the anticodon, whereas the second central base (U36) was described to participate in a weaker interaction. Only N3 of U36 forms a hydrogen bond with the main chain carbonyl group of Cys231 (Kobayashi et al., 2003) , a residue mutated in this study. Indeed, the substitution of Cys231 by Ile maintained the tRNA specificity and at the same time appeared to favour the aminoacylation activity of the aaRS.
The second exchanged Cys residue (Cys159) had been introduced during selection of the original Apa-specific synthetase, ApaRS#0. Considering that this residue is located directly in the active site adjacent to Gln160, a position mutated during selection of ApaRS#B4, it seems to play a role for substrate recognition, too. Interestingly, in our positional saturation mutagenesis, Cys159 was preferentially replaced by Ala such that the substrate pocket gains even more space to bind the elongated and more voluminous Apa compared with Tyr. However, the substitution of Cys by Ala resulted in slightly reduced activity, indicating that the original effect was only insufficiently retained with a smaller side chain at this position. Nevertheless, neither Cys nor Thrpreviously found as an alternative side chain at this position (Turner et al., 2005) -predominated after this selection experiment, indicating that Cys may be less beneficial. Indeed, in combination with the improved suppressor tRNA#B5, ApaRS#H8 appeared as the most effective synthetase variant.
Up to now, there has been a lot of effort to increase recombinant protein yields in the context of amber suppression with engineered Mj aaRS&tRNA pairs. Several studies aimed at either optimising the genetic structure of the plasmid that harbours the genes for the aaRS and the tRNA (Kuhn et al., 2010; or at improving the tRNA or aaRS sequences themselves. All attempts to select an orthogonal suppressor tRNA or to improve its interaction with EF-Tu and/or the ribosome in order to boost amber suppression (Guo et al., 2009) were made by using focused libraries. In contrast, we applied an error-prone PCR library of the entire engineered suppressor tRNA previously derived from Mj tRNA Tyr in conjunction with our fluorescence-based one-plasmid selection/screening system, which allowed us to specifically tune the tRNA towards the Apa-specific orthogonal synthetase. Remarkably, just one new nucleotide exchange, U46G in the 'variable' tRNA region, was sufficient to achieve an 8-fold higher level of protein biosynthesis after 6 h induction. The practical utility of our one-plasmid system was finally demonstrated by expressing an ED-B specific Anticalin with a reactive keto side chain via site-specific incorporation of Apa. To this end, the eGFP reporter gene was simply replaced by the coding region for the engineered lipocalin, including an N-terminal signal peptide (Gebauer et al., 2013) . The new functional amino acid side chain was subsequently employed to covalently attach a fluorescent dye. In the context of Anticalin technology, this approach offers two benefits. First, the site-specific labelling at a functionally and structurally permissive position remote from the binding site avoids interference with target association. Notably, with decreasing size of engineered binding proteins, including Anticalins (Richter et al., 2014) , small antibody fragments or other alternative scaffolds (Gebauer and Skerra, 2009) , the risk of affecting the binding properties after labelling of Lys side chains increases if compared with large intact antibodies. Second, introduction of a single unpaired Cys side chain for the site-specific labelling is no longer necessary. While this constitutes a widely used alternative strategy to Lys conjugation, it is usually accompanied by reduced expression yields as well as isomer formation for proteins that carry structural disulphide bridges. Remarkably, secretion of the Anticalin out of the reducing milieu of the E.coli cytoplasm-to ensure formation of its disulphide bond-was efficiently possible with our oneplasmid system, even though periplasmic protein expression often represents an additional stress factor for the bacterial host cell.
The derivatisation of recombinant proteins using an orthogonal chemistry provided by Apa inserted at a defined position is not limited to spectroscopic probes. Tumour-specific Anticalins such as N7A also offer the possibility of specific tageting in vivo and therefore open the field for therapeutic applications (Richter et al., 2014) . Arming such a keto-derivatised Anticalin via site-specific coupling with a small molecule toxin or a radiometal chelator would be a promising approach for tumour therapy and/or diagnostics, for example in connection with in vivo PET imaging.
Materials and methods
ApaRS library construction
To obtain the ApaRS#0 gene, four amino acid exchanges were introduced into the wild-type Mj TyrRS gene cloned on plasmid pSB4.1c2 (Kuhn et al., 2010) via Kunkel mutagenesis (Geisselsoder et al., 1987) . A random library based on the ApaRS#0 gene was constructed using error-prone PCR with the GeneMorph II random mutagenesis kit (Stratagene, Heidelberg, Germany). First, the 606 bp cassette was amplified with a high-fidelity DNA polymerase using the primers ep1 and ep2 (Kuhn et al., 2010) in 50 µl comprising 1xPfu Ultra II buffer, 200 µM of each dNTP, 1 mM Mg 2+ , 10 ng plasmid DNA template, 0.5 µM of each primer and 0.5 U Pfu Ultra II DNA polymerase (Agilent, La Jolla, CA). The reaction mix was incubated at 95°C for 2 min, followed by 30 cycles of 30 s at 95°C , 30 s at 56°C and 1 min at 72°C, followed by final incubation at 72°C for 10 min. After agarose gel purification of the PCR product using the Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany) re-amplification was performed in 50 µl with 1× Mutazyme II reaction buffer, 200 µM of each dNTP, 0.1 ng DNA template, 0.5 µM of each primer and 2.5 U Mutazyme II DNA polymerase by applying the thermocycles described above. Agarose gel purification yielded ∼1.5 µg PCR product carrying on average two to four nucleotide mutations in the amplified region, as confirmed by automated DNA sequencing (ABI Prism 310 Genetic Analyzer; Applied Biosystems, Weiterstadt, Germany).
The resulting DNA fragment was doubly cut with EarI, again purified by agarose gel eletrophoresis and cloned on the plasmid pSB4.8c2 (Kuhn et al., 2010) . Transformation (Dower et al., 1988) of electrocompetent E.coli XL1-blue (Bullock et al., 1987) yielded a library of 5 × 10 8 transformants, which were plated on 10 square LB agar plates (114 cm   2 ; Greiner Bio-One, Frickenhausen, Germany) supplemented with 30 mg/l chloramphenicol. Colonies were scraped from the plates and resuspended in 5 ml LB medium each (Sambrook and Russell, 2001) , then combined and adjusted to a volume of 1 l. After incubation at 30°C under shaking for 30 min, plasmid DNA was prepared from this pooled culture by means of the Qiagen Plasmid Midi Kit and subsequently used for transformation of electrocompetent E.coli BL21 (Studier and Moffatt, 1986) .
A focused ApaRS library with fully randomised positions Cys159 and Cys231 was generated using a pair of NNS-degenerate PCR primers and Pfu Ultra II DNA polymerase. To this end, first two overlapping PCR fragments were prepared, each using a pair of primers: one spanning the central part of the ApaRS#A10 gene cassette with primers covering the two mutation sites (forward primer: 5′-ATCCAA TAATGCAGGTTAATGGTNNSCAATA TCGAGGTGTTG-3′; reverse primer: 5′-CCCGTTAAGACAGGGTTGTGAATSNNAACA ACCTTTTTT GGTAAAAGC-3′) and the other one to amplify the vector backbone of pSB4.10c2 (forward primer: 5′-CACAACCCTGTC TTAACGGG-3′; reverse primer: 5′-ATTAACCTGCATTATTGGA TA-3′). To remove the bacterial plasmid template, an enzymatic digest with DpnI was performed at 37°C for 2 h and both DNA fragments were purified by agarose gel electrophoresis. For subsequent assembly via PCR, 200 ng of the vector amplification product was mixed with 25 ng of the insert (i.e. at equal molar ratio) in 25 µl containing Pfu Ultra II DNA polymerase reaction mixture without primers. The mixture was initially denatured for 30 s at 98°C, annealed for 30 s at 55°C, and a linear polymerase reaction was then performed for 4 min at 72°C. After desalting the reaction mixture using the Quiagen PCR Purification Kit, 14 µl of the DNA solution was used for electrotransformation of E.coli XL1-blue, yielding 6 × 10 7 transformants. Colonies were combined in one culture and pooled plasmid DNA was isolated as above, followed by electrotransformation of E.coli BL21. In order to avoid any influence that might have arisen from accidental mutation in other parts of the vector, for example in regulatory regions, the central aaRS gene cassette was excised via either the pair of EarI restriction sites (random libraries) or AvrII in combination with SacI (focused library) and recloned on pSB4 for those variants that were subjected to detailed analysis (cf. Table I) .
tRNA library construction
A random library based on the tRNA#0 gene, previously published as tRNA opt CUA , was constructed by error-prone PCR using the GeneMorph II random mutagenesis kit in a similar fashion as for the ApaRS coding region described above. First, the template tRNA#0 gene including the adjacent lpp promoter and rrnC transcription terminator was amplified with 0.5 units of Pfu Ultra II DNA polymerase and 0.5 μM primers 5′-CCGATTTCGGCCTATTGG-3′ and 5′-CATGCCATACCGCGAAAG-3′ in the presence of 200 µM of each dNTP, 10 ng template DNA and the supplied Pfu Ultra II buffer in a total volume of 50 μl. PCR was performed with an initial denaturation step for 2 min at 95°C, 30 cycles of 30 s at 95°C, 30 s at 58°C and 1 min at 72°C, followed by a final incubation of 5 min at 72°C. The PCR product was purified via agarose gel electrophoresis using the Qiagen gel extraction kit. To introduce mutations into the tRNA#0 sequence, re-amplification was performed in 50 µl using 0.1 ng template DNA and the GeneMorph II random mutagenesis kit under the same conditions as described further above. After agarose gel purification, ∼0.5 µg PCR product carrying on average one to two nucleotide mutations in the amplified region was obtained. This amplification product was digested with PstI and EcoRI, purified, and recloned on pSB4.11c2. The PstI and EcoRI restriction sites were located directly at the 5′ and 3′ end, respectively, of the tRNA coding region (Kuhn et al., 2010) , thus avoiding any mutations in the lpp promoter or rrnC terminator that may have arisen from the error-prone PCR. Transformation of electrocompetent E.coli XL1-blue yielded a library of 1 × 10 7 transformants from which plasmid DNA was prepared as described above and used for transformation of electrocompetent E.coli BL21.
Flow cytofluorimetry and cell sorting
Bacterial cell sorting experiments were performed with the pSB4 oneplasmid system using the E.coli strain BL21 essentially as described before (Kuhn et al., 2010) . Freshly transformed bacteria were diluted into 2 l LB medium (Sambrook and Russell, 2001 ) containing 30 mg/l chloramphenicol and grown at 37°C to OD 550 = 0.4 in a 5 l shake flask. From this culture, triplicates of 2 ml were transferred into plastic tubes and supplemented in parallel with either 1 mM Tyr (Sigma-Aldrich, Munich, Germany) or 1 mM Apa (synthesised as described further below; Takasu et al., 2011) , each freshly dissolved as a 200 mM solution in 200 mM NaOH. aaRS expression was immediately induced by addition of 50 ng/ml anhydrotetracycline (aTc; Acros Organics, Geel, Belgium) dissolved at 2 mg/ml in dimethylformamide (DMF). Bacteria were grown under shaking at 37°C for 1 h, then expression of eGFP was induced by addition of 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG; Formedium, Hunstanton, UK) from a 1 M stock solution in ddH 2 O, followed by shaking at 37°C for another 9-12 h. Then, 1 ml of each culture was centrifuged in a 1.5 ml Eppendorf tube for 3 min, and the bacterial pellet was carefully resuspended by repeated pipetting with 1 ml filter-sterilised M9 minimal medium (Sambrook and Russell, 2001) . After washing twice according to this procedure, the bacteria were finally resuspended in the same volume of minimal medium. Flow cytofluorimetric analysis and bacterial cell sorting were performed on a FACSAria instrument (BD Biosciences, Heidelberg, Germany) which was operated with filter-sterilised phosphatebuffered saline (PBS; 4 mM KH 2 PO 4 , 16 mM Na 2 HPO 4 , 115 mM NaCl) as sheath fluid, using a 488 nm LASER for excitation and a 502 nm long-pass filter with a 530/30 band-pass filter for specific detection of eGFP fluorescence. Data were analysed with FlowJo software (Tree Star, Ashland, OR). After selecting intact cells via an appropriate FSC/SSC gate, the final sort gates for each population were dynamically set to select those cells belonging to the fraction of 1-5% of total cells with the highest eGFP signal intensities in the presence of Apa for 'positive selection' cycles. For 'negative selection', cells with low eGFP signal, comparable with that of uninduced bacteria, were sorted. Bacteria were directly collected in LB medium supplemented with 30 mg/l chloramphenicol and thermostated at 37°C. For reamplification, the sorted cells were plated on LB agar containing 1% (w/v) glucose and 30 mg/l chloramphenicol and incubated at 37°C over night. The lawn of colonies was collectively resuspended in LB medium as described further above. A 2 ml aliquot of this dense bacterial cell suspension was prepared as glycerol stock by adding 70% (v/v) glycerol 1:1 to the culture and freezing at −80°C; another 2 ml of the cell suspension was used to inoculate 100 ml freshly prepared LB medium supplemented with 30 mg/l chloramphenicol to be directly used for the next selection cycle.
Screening of aaRS libraries on a robotic platform
Automated screening of bacterial clones was performed in the 96-well format on a Lab Star plus liquid handling station (Hamilton Robotics, Bondaduz, Switzerland) equipped with an EASYPICK imaging system, a BVS vacuum system and a Synergy 2 SLFA microplate reader (BioTek Instruments, Bad Friedrichshall, Germany). After FACS, the plasmid pools from sorted cells harbouring the mutated aaRS or tRNA genes were prepared and used for transformation of E.coli BL21, followed by plating on LB agar supplemented with 30 mg/l chloramphenicol in a rectangular plastic dish (Nunc, Langenselbold, Germany). On the next day, colonies were automatically picked and used to inoculate 100 μl TB medium (Sambrook and Russell, 2001) supplemented with 30 mg/l chloramphenicol in 96-well round bottom microtiter plates (Sarstedt, Nurnbrecht, Germany). E.coli BL21 transformed with a pSB4.8c vector that carried a multiple cloning site instead of the eGFP reporter gene was used as negative control.
The microtiter plate was sealed with a gas-permeable Breathseal 80/140 mm membrane (Greiner Bio-One) and incubated overnight to stationary phase at 37°C under 300 rpm agitation, using an orbital shaking Minitron incubator with 25 mm amplitude (Infors, Eisenbach, Germany). Then, fresh 1 ml cultures in TB medium containing 30 mg/l chloramphenicol were inoculated in Masterblock 2 ml V-shape deep-well microtiter plates (Greiner Bio-One) each with 20 μl of the pre-culture and incubated for ∼2 h at 37°C to reach OD 550 ≈ 0.4 as monitored with the Synergy 2 microplate reader. This inoculation was done in duplicate using two equivalent 96 deep-well plates, one to be supplemented with Apa and the other one with Tyr.
Then, the aaRS gene was induced by adding 20 µl of a 2.5 µg/ml aqueous solution of aTc, diluted from a 2 mg/ml stock solution in DMF. Immediately thereafter, Apa was added to one plate and Tyr to the other one, each at a final concentration of 1 mM (using 20 µl from a 50 mM stock solution). After further shaking for 1 h, the cells were induced with 1 mM IPTG (by adding 20 µl from a 50 mM stock solution). Bacterial growth was continued at 37°C for 12 h; then, the cultures were centrifuged (3857 × g; 15 min) and resuspended in 1 ml PBS by repeated pipetting on the robotic platform. Washing in PBS was repeated once. Finally, eGFP fluorescence of a 100 µl aliquot was measured in the cell suspension using Maxisorb black 96-well assay plates (Nunc) by means of excitation at 485 ± 10 nm and emission at 528 ± 10 nm. Fluorescence readings of each well were normalised to the OD 550 measured by reading absorption of the same cell suspension, diluted 1:5 (20 µl aliquot plus 80 µl PBS), in a 96-well Mikrotest plate F (Sarstedt). The normalised background fluorescence of two wells with cells harbouring just the empty pSB4.8c backbone (encoding no eGFP) was averaged and subtracted from all other fluorescence readings. Final values were reported as fluorescence ratio aaRS +Apa /aaRS +Tyr for each clone.
Biosynthetic protein expression and purification
Preparative expression of eGFP Apa39 was performed in E.coli BL21 in 1 l LB medium supplemented with 30 mg/l chloramphenicol. Cultures were grown at 30°C to an OD 550 of 0.4, then Apa was added to 1 mM and ApaRS#H8 expression was induced with 50 ng/ml aTc. The cells were incubated for 1 h at 30°C, followed by induction of eGFP UAG gene expression with 1 mM IPTG. Growth was continued at 30°C for 12 h before harvest by centrifugation. The cell sediment was suspended in 20 ml of cold SA buffer (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA) and disrupted using a French-Press homogeniser (SLM Aminco, Urbana, IL). The extract was cleared by centrifugation and the supernatant was filtered through a Filtropur S 0.2 μm sterile filter (Sarstedt). The biosynthetic protein was purified via streptavidin affinity chromatography (SAC) according to published procedures (Schmidt and Skerra, 2007) . Fractions containing eGFP Apa39 were pooled and dialysed against 100 mM Tris-HCl pH 8.0 and further purified by AEX on a 1 ml Resource Q column (GE Healthcare, Freiburg, Germany) equilibrated with the dialysis buffer. Protein fractions eluting at around 210 mM NaCl in a linear salt concentration gradient were used for further analysis. For comparison, eGFP Tyr39 was produced in the same manner using a vector encoding wild-type Mj TyrRS in the context of tRNA#0. An amber stop codon (Gln20UAG) was introduced into the coding region for the Anticalin N7A (Gebauer et al., 2013) by site-directed mutagenesis using pNGAL98-N7A as template, followed by subcloning via XbaI and HindIII on pSB4.12e15. Preparative protein expression of N7A Apa20 was accomplished using E.coli BL21, which was inoculated in 1 l M9 minimal medium (Sambrook and Russell, 2001 ) supplemented with 30 mg/l chloramphenicol. Cultures were grown at 22°C to OD 550 = 0.4; then, 1 mM Apa was added and ApaRS#H8 expression was induced with 50 ng/ml aTc. The culture was incubated for 1 h at 22°C, then N7A Apa20 gene expression was induced with 1 mM IPTG. Incubation was continued at 22°C for 12-16 h prior to harvest by centrifugation. N7A Apa20 was purified via SAC essentially as described above. The eluted fractions were diluted 1:1 with 50 mM MES/NaOH pH 5.5 and further purified by CEX on a 1 ml Resource S column (GE Healthcare) equilibrated with the same buffer. The Anticalin was eluted using a linear concentration gradient of 0-500 mM NaCl. Protein purity was confirmed by SDS-PAGE (Fling and Gregerson, 1986) using Coomassie brilliant blue R-250 (AppliChem, Darmstadt, Germany) for staining. Protein concentration was determined via absorption at 280 nm using a calculated extinction coefficient (after substituting the NCAA by Tyr) of 27 390 M -1 cm −1 for eGFP Apa39 and of 38 055 M −1 cm −1 for N7A Apa20 with the ProtParam tool on the ExPASy server (Gasteiger et al., 2003) . The molecular mass was confirmed by ESI-MS on an maXis Q-TOF instrument (Bruker, Bremen, Germany) operated in positive ion mode after dialysis against 10 mM ammonium acetate (pH 6.6). In vitro protein modification with Alexa Fluor 488 and fluorescence microscopy After CEX, the purified biosynthetic N7A Apa20 was already in a suitable buffer for chemical coupling (i.e. 50 mM MES/NaOH pH 5.5, ∼0.3 M NaCl). Alexa Fluor 488 hydroxylamine (Molecular Probes, Darmstadt, Germany) was dissolved in dimethyl sulphoxide to obtain a 50 mM stock solution. A 45 µl aliquot of this dye solution was added to 45 µmol of N7A Apa20 protein (∼1 mg/ml) in a total volume of 1 ml, corresponding to a molar ratio of 50:1 (dye:protein). The reaction mixture was incubated at 25°C for 18 h and unreacted dye was finally removed by gel filtration on a PD-10 column (GE Healthcare) equilibrated with PBS. Human cancer colon cells, CaCo2, were cultivated and prepared for immune staining as previously described (Gebauer et al., 2013) . Cells were fixed and counterstained by 5 min incubation with ice-cold methanol containing 5 μg/ml 4′,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich). Then, the cells were washed twice with distilled water and incubated for 1 h with 200 μl of a 1 μM solution of the N7A Apa20 -Alexa488 conjugate from above, followed by washing with PBS. A control experiment under the same conditions was performed with addition of a 100-fold excess of the unmodified N7A protein (without keto derivatisation), which was prepared as described (Gebauer et al., 2013) . Digital images were collected with an Axiovert 40 CFL microscope (Carl Zeiss Microscopy, Jena, Germany) equipped with an AxioCam camera using band-pass filters BP450-490 (DyLight-488/fluorescein, green) and BP365/12 (DAPI, blue).
Chemical synthesis of Apa
N-Acetyl-L-phenylalanine ethyl ester (2)
L-Phenylalanine ethyl ester hydrochloride (1) (100 g, 435 mmol; Iris Biotech, Marktredwitz, Germany) was dissolved in 100 ml dichloromethane and 105 ml pyridine. The solution was cooled to 0°C and acetic acid anhydride (82.3 ml, 89 g, 870 mmol) was added dropwise over 30 min. The mixture was allowed to warm to room temperature and was stirred for 16 h. The solvent was removed using a rotary
